These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8786639)

  • 1. Novel benzodioxan derivative, 5-(3-[((2S)-1,4-benzodioxan-2- ylmethyl)amino]propoxy)-1,3-benzodioxole HCl (MKC-242), with a highly potent and selective agonist activity at rat central serotonin1A receptors.
    Matsuda T; Yoshikawa T; Suzuki M; Asano S; Somboonthum P; Takuma K; Nakano Y; Morita T; Nakasu Y; Kim HS
    Jpn J Pharmacol; 1995 Dec; 69(4):357-66. PubMed ID: 8786639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of orally administered 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole (MKC-242) with 5-HT1A receptors in rat brain.
    Asano S; Matsuda T; Yoshikawa T; Somboonthum P; Tasaki H; Abe M; Baba A
    Jpn J Pharmacol; 1997 May; 74(1):69-75. PubMed ID: 9195299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MKC-242, a novel 5-HT1A receptor agonist, facilitates cortical acetylcholine release by a mechanism different from that of 8-OH-DPAT in awake rats.
    Somboonthum P; Matsuda T; Asano S; Sakaue M; Baba A
    Neuropharmacology; 1997; 36(11-12):1733-9. PubMed ID: 9517445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl) amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models.
    Abe M; Tabata R; Saito K; Matsuda T; Baba A; Egawa M
    J Pharmacol Exp Ther; 1996 Aug; 278(2):898-905. PubMed ID: 8768745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), a novel 5-HT1A-receptor agonist, on aggressive behavior and marble burying behavior in mice.
    Abe M; Nakai H; Tabata R; Saito K; Egawa M
    Jpn J Pharmacol; 1998 Mar; 76(3):297-304. PubMed ID: 9593223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like effect by postsynaptic 5-HT1A receptor activation in mice.
    Matsuda T; Somboonthum P; Suzuki M; Asano S; Baba A
    Eur J Pharmacol; 1995 Jul; 280(2):235-8. PubMed ID: 7589193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation.
    Suzuki M; Matsuda T; Asano S; Somboonthum P; Takuma K; Baba A
    Br J Pharmacol; 1995 Jun; 115(4):703-11. PubMed ID: 7582494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of wrap restraint stress-induced defecation by MKC-242, a novel benzodioxan derivative, via 5-HT1A-receptor agonist action in rats.
    Abe M; Saito K
    Jpn J Pharmacol; 1998 Jul; 77(3):211-7. PubMed ID: 9717768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiating action of MKC-242, a selective 5-HT1A receptor agonist, on the photic entrainment of the circadian activity rhythm in hamsters.
    Moriya T; Yoshinobu Y; Ikeda M; Yokota S; Akiyama M; Shibata S
    Br J Pharmacol; 1998 Nov; 125(6):1281-7. PubMed ID: 9863658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex.
    Sakaue M; Somboonthum P; Nishihara B; Koyama Y; Hashimoto H; Baba A; Matsuda T
    Br J Pharmacol; 2000 Mar; 129(5):1028-34. PubMed ID: 10696105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-HT1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze.
    Sakaue M; Ago Y; Sowa C; Koyama Y; Baba A; Matsuda T
    Eur J Pharmacol; 2003 Jan; 458(1-2):141-4. PubMed ID: 12498918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective reduction by isolation rearing of 5-HT1A receptor-mediated dopamine release in vivo in the frontal cortex of mice.
    Ago Y; Sakaue M; Baba A; Matsuda T
    J Neurochem; 2002 Oct; 83(2):353-9. PubMed ID: 12423245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended action of MKC-242, a selective 5-HT(1A) receptor agonist, on light-induced Per gene expression in the suprachiasmatic nucleus in mice.
    Takahashi S; Yoshinobu Y; Aida R; Shimomura H; Akiyama M; Moriya T; Shibata S
    J Neurosci Res; 2002 May; 68(4):470-8. PubMed ID: 11992474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Gobert A; Widdowson P; Bervoets K; Brocco M; Peglion JL
    Eur J Pharmacol; 1993 Jan; 230(1):99-102. PubMed ID: 8381359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of benzodiazepine binding sites in an antiaggressive effect by 5-HT(1A) receptor activation in isolated mice.
    Sakaue M; Ago Y; Murakami C; Sowa C; Sakamoto Y; Koyama Y; Baba A; Matsuda T
    Eur J Pharmacol; 2001 Dec; 432(2-3):163-6. PubMed ID: 11740952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory action of 5-HT1A agonist MKC-242 on triazolam-induced phase advances in hamster circadian activity rhythms.
    Yokota S; Moriya T; Shibata S
    J Pharmacol Sci; 2005 May; 98(1):103-6. PubMed ID: 15879674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.